Friess Associates LLC Abbott Laboratories Transaction History

Friess Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $8.09 Million - $10.4 Million	-105,675 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $10.2 Million - $15 Million	-163,131 Reduced 60.69%	105,675 $8.34 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $12,846 - $15,531	-194 Reduced 0.07%	268,806 $21.5 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $15.1 Million - $17.1 Million	269,000 New	269,000 $16.1 Million

3,208

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.